BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29620897)

  • 21. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT
    Kim J; Kim YJ; Londhe AM; Pae AN; Choo H; Kim HJ; Min SJ
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31491978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin 2C receptor antagonism ameliorates novelty-induced hypophagia in aged mice.
    Nahata M; Muto S; Nakagawa K; Ohnishi S; Sadakane C; Saegusa Y; Iizuka S; Hattori T; Asaka M; Takeda H
    Psychoneuroendocrinology; 2013 Oct; 38(10):2051-64. PubMed ID: 23583320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
    Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
    J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.
    Filip M; Bubar MJ; Cunningham KA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1246-54. PubMed ID: 15131246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence.
    Anastasio NC; Stutz SJ; Fox RG; Sears RM; Emeson RB; DiLeone RJ; O'Neil RT; Fink LH; Li D; Green TA; Moeller FG; Cunningham KA
    Neuropsychopharmacology; 2014 Jan; 39(2):370-82. PubMed ID: 23939424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT
    Kim J; Jo H; Lee H; Choo H; Kim HJ; Pae AN; Cho YS; Min SJ
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28846591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
    Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective effects of 5-HT2C receptor modulation on performance of a novel valence-probe visual discrimination task and probabilistic reversal learning in mice.
    Phillips BU; Dewan S; Nilsson SRO; Robbins TW; Heath CJ; Saksida LM; Bussey TJ; Alsiö J
    Psychopharmacology (Berl); 2018 Jul; 235(7):2101-2111. PubMed ID: 29682701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.
    Storer RI; Brennan PE; Brown AD; Bungay PJ; Conlon KM; Corbett MS; DePianta RP; Fish PV; Heifetz A; Ho DK; Jessiman AS; McMurray G; de Oliveira CA; Roberts LR; Root JA; Shanmugasundaram V; Shapiro MJ; Skerten M; Westbrook D; Wheeler S; Whitlock GA; Wright J
    J Med Chem; 2014 Jun; 57(12):5258-69. PubMed ID: 24878222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.
    Martin CB; Martin VS; Trigo JM; Chevarin C; Maldonado R; Fink LH; Cunningham KA; Hamon M; Lanfumey L; Mongeau R
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
    Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
    J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coevolution of Residues Provides Evidence of a Functional Heterodimer of 5-HT
    Fongang B; Cunningham KA; Rowicka M; Kudlicki A
    Neuroscience; 2019 Aug; 412():48-59. PubMed ID: 31158438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Action of Cassiae Semen for Weight Management: A Computational Molecular Docking Study of Serotonin Receptor 5-HT2C.
    Yuen H; Hung A; Yang AWH; Lenon GB
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
    Brennan PE; Whitlock GA; Ho DK; Conlon K; McMurray G
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4999-5003. PubMed ID: 19646865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptor.
    Piscitelli F; Ligresti A; La Regina G; Coluccia A; Morera L; Allarà M; Novellino E; Di Marzo V; Silvestri R
    J Med Chem; 2012 Jun; 55(11):5627-31. PubMed ID: 22571451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
    De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
    J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.
    Tye H; Mueller SG; Prestle J; Scheuerer S; Schindler M; Nosse B; Prevost N; Brown CJ; Heifetz A; Moeller C; Pedret-Dunn A; Whittaker M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):34-7. PubMed ID: 21146986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous Serotonin 5-HT
    Price AE; Sholler DJ; Stutz SJ; Anastasio NC; Cunningham KA
    ACS Chem Neurosci; 2019 Jul; 10(7):3241-3248. PubMed ID: 30645940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.